Double discovery boosts global quest for leukaemia cures

Snowdome-supported researchers at Peter MacCallum Cancer Centre have discovered how a form of leukaemia fights back against a ground-breaking treatment, providing vital new leads on how to outwit the deadly disease. Acute Myeloid Leukaemia (AML)

Read More
recently approved research projects

Over the last 9 months, Snowdome’s funding efforts have been concentrated on directing just over $1,000,000 into epigenetic treatments for Australians with blood cancers. Snowdome has worked with several passionate donors to invest over $750,000

Read More
supporting ‘global best practice’

Throughout 2013/14, Snowdome was successful in joining several like-minded major donors* to establish the Centre of Research Excellence in Myeloma (CRE-M) in Melbourne. This $3million investment will support a global best practice research approach in

Read More
an update on recent accomplishments

We are proud to share that 215 Australian blood cancer patients have gained access to new, cutting-edge therapies since Snowdome formed in 2010. This year has been a record-breaking year in fund raising for Snowdome,

Read More
A Researcher’s Insight – Azacitidine/Eltrombopag study

In a final analysis of the Peter Mac sponsored Azacitidine/Eltrombopag study, haematologist and research fellow, Dr Michael Dickinson, targets myelodysplastic syndromes and gives us a lay summary of the purpose of the trial.  Myelodysplastic syndromes

Read More
‘making hope real’ for patients with MDS

In June this year at the European Haematology Association meeting in Italy, Dr Melita Kenealy, project manager of the Victorian Epigenetics Group, presented the first results of her recently led, large Australian study for patients

Read More
Snowflake Snowflake Snowflake Snowflake Snowflake Snowflake

You can help more than you know

Please donate now